Abbott Plans to Spin Off Nutrition Business by 2027
The company says the separation will create a listed nutrition business and leave Abbott focused on devices, diagnostics and medicines.
Makkler Newsroom · Oct 21, 06:59 PM · 1 min read
Abbott Laboratories ABT
NYSEHealth TechnologyUnited States
$108.52+1.27 (+1.18%)
Market closed· · USD · Data may be delayed
- Day's range
- 107.03109.28
- 52-week range
- 81.97132.03
Financial health
– / 5
Analyst view · 31 firms
Buy23 buy · 8 hold · 0 sell
Avg. target $119.46 (+10.1%)
Prices may be delayed and are for informational purposes only - not investment advice.